Wird geladen...
Nonvitamin K antagonist oral anticoagulant activity: challenges in measurement and reversal
BACKGROUND: Four nonvitamin K antagonist oral anticoagulants (NOACs) are approved for the prevention of stroke in patients with nonvalvular atrial fibrillation and for the treatment of venous thromboembolism. These include the direct thrombin inhibitor dabigatran and the direct factor Xa inhibitors...
Gespeichert in:
| Veröffentlicht in: | Crit Care |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5034528/ https://ncbi.nlm.nih.gov/pubmed/27659071 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-016-1422-2 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|